Cargando…
Mesenchymal stem cells in cancer therapy; the art of harnessing a foe to a friend
For a long time, mesenchymal stem cells (MSCs) were discussed only as stem cells which could give rise to different types of cells. However, when it became clear that their presence in the tumor microenvironment (TME) was like a green light for tumorigenesis, they emerged from the ashes. This review...
Autores principales: | Karimi-Shahri, Mehdi, Javid, Hossein, Sharbaf Mashhad, Alireza, Yazdani, Shaghayegh, Hashemy, Seyed Isaac |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mashhad University of Medical Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769515/ https://www.ncbi.nlm.nih.gov/pubmed/35096289 http://dx.doi.org/10.22038/IJBMS.2021.58227.12934 |
Ejemplares similares
-
The role of viruses in cancer development versus cancer therapy: An oncological perspective
por: Javid, Hossein, et al.
Publicado: (2023) -
Mesenchymal stroma/stem cells: Haematologists’ friend or foe?
por: Nachmias, Boaz, et al.
Publicado: (2022) -
Mesenchymal Stem Cell: A Friend or Foe in Anti-Tumor Immunity
por: Harrell, Carl Randall, et al.
Publicado: (2021) -
Endothelial-to-Mesenchymal Transition in Atherosclerosis: Friend or Foe?
por: Gole, Sarin, et al.
Publicado: (2022) -
ZEB Proteins in Leukemia: Friends, Foes, or Friendly Foes?
por: Soen, Bieke, et al.
Publicado: (2018)